In a lawsuit against a group of drug companies, the city of Chicago and its outside lawyers at Cohen, Milstein, Sellers & Toll described a concerted—and allegedly deceptive—marketing effort to brighten the medical community’s view of addictive painkillers. What the city didn’t detail, at least to the satisfaction of a federal judge, were specific examples of deception in the companies’ interactions with doctors.
U.S. Circuit Judge Jorge Alonso on Friday dismissed most of the city’s suit, which alleges that several drug manufacturers concealed the true addiction risks of opioid painkillers. The judge held that the complaint’s claims of deceptive marketing and misrepresentations weren’t specific enough.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
